Many have probably seen the reports of the antibiotic “superbug” CRE breakout at UCLA Medical Center, and now Denver Health Medical Center and another will be studying the bug thanks to a recent grant.
According to the Denver Post, Denver Health and Accelerate Diagnostics were awarded a grant to develop a fast and reliable diagnostic test to detect common bacteria directly from blood—and to determine antibiotic susceptibility—all within a few hours. CRE stands for carbapenem-resistant Enterobacteriaceae, and the disease has been linked to difficult-to-clean medical scopes.
The grant was for $5 million and was given by the National Institutes of Health.
This local update courtesy of your Denver South Community Expert.